PCI Biotech Holding ASA (PCIB.OL)

NOK 1.32

(-0.75%)

Revenue Summary of PCI Biotech Holding ASA

  • PCI Biotech Holding ASA's latest annual revenue in 2023 was 2.99 Million NOK , down 0.0% from previous year.
  • PCI Biotech Holding ASA's latest quarterly revenue in 2024 Q2 was 1.71 Million NOK , down 0.0% from previous quarter.
  • PCI Biotech Holding ASA reported a annual revenue of - NOK in annual revenue 2022, down 0.0% from previous year.
  • PCI Biotech Holding ASA reported a annual revenue of - NOK in annual revenue 2021, down 0.0% from previous year.
  • PCI Biotech Holding ASA reported a quarterly revenue of 1.71 Million NOK for 2024 Q2, down 0.0% from previous quarter.
  • PCI Biotech Holding ASA reported a quarterly revenue of - NOK for 2023 Q2, down 0.0% from previous quarter.

Annual Revenue Chart of PCI Biotech Holding ASA (2023 - 2008)

Created with Highcharts 11.1.0YearsRevenue20082009201020112012201320142015201620172018201920202021202220230 NOK2500000 NOK5000000 NOK7500000 NOK10000000 NOK12500000 NOK

Historical Annual Revenue of PCI Biotech Holding ASA (2023 - 2008)

Year Revenue Revenue Growth
2023 2.99 Million NOK 0.0%
2022 - NOK 0.0%
2021 - NOK 0.0%
2020 - NOK 0.0%
2019 - NOK 0.0%
2018 - NOK 0.0%
2017 - NOK 0.0%
2016 - NOK 0.0%
2015 - NOK 0.0%
2014 - NOK 0.0%
2013 - NOK 0.0%
2012 - NOK -100.0%
2011 7.42 Million NOK -28.93%
2010 10.44 Million NOK 21.27%
2009 8.61 Million NOK 16.9%
2008 7.36 Million NOK 0.0%

Peer Revenue Comparison of PCI Biotech Holding ASA

Name Revenue Revenue Difference
Arctic Bioscience AS 33.75 Million NOK 91.141%
Aqua Bio Technology ASA 1.55 Million NOK -91.703%
ArcticZymes Technologies ASA 118.93 Million NOK 97.486%
BerGenBio ASA 354 Thousand NOK -744.633%
Hofseth BioCare ASA 194.87 Million NOK 98.466%
Thor Medical ASA - NOK -Infinity%
Ultimovacs ASA - NOK -Infinity%